Trends in underlying causes of death in people with HIV from 1999 to 2011 (D: A: D): a multicohort collaboration
Background With the advent of effective antiretroviral treatment, the life expectancy for
people with HIV is now approaching that seen in the general population. Consequently, the …
people with HIV is now approaching that seen in the general population. Consequently, the …
Projected life expectancy of people with HIV according to timing of diagnosis
F Nakagawa, RK Lodwick, CJ Smith, R Smith… - Aids, 2012 - journals.lww.com
Methods: A stochastic computer simulation model of HIV infection and the effect of ART was
used to estimate life expectancy and determine the distribution of potential lifetime outcomes …
used to estimate life expectancy and determine the distribution of potential lifetime outcomes …
Estimation of the worldwide seroprevalence of cytomegalovirus: a systematic review and meta‐analysis
…, GSA Smit, G Wallis, F Jabbar, C Smith… - Reviews in medical …, 2019 - Wiley Online Library
Cytomegalovirus (CMV) infection does not usually produce symptoms when it causes
primary infection, reinfection, or reactivation because these three types of infection are all …
primary infection, reinfection, or reactivation because these three types of infection are all …
Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension
…, CE Handler, R Akram, CJ Smith… - European heart …, 2006 - academic.oup.com
Aims The aims of this study were to evaluate the diagnostic value and to explore the
prognostic value of N-terminal brain natriuretic peptide (N-TproBNP) in patients with systemic …
prognostic value of N-terminal brain natriuretic peptide (N-TproBNP) in patients with systemic …
[HTML][HTML] Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial
PD Griffiths, A Stanton, E McCarrell, C Smith, M Osman… - The Lancet, 2011 - thelancet.com
Background Cytomegalovirus end-organ disease can be prevented by giving ganciclovir
when viraemia is detected in allograft recipients. Values of viral load correlate with …
when viraemia is detected in allograft recipients. Values of viral load correlate with …
Systemic Amyloidosis in E ngland: an epidemiological study
JH Pinney, CJ Smith, JB Taube… - British journal of …, 2013 - Wiley Online Library
Epidemiological studies of systemic amyloidosis are scarce and the burden of disease in E
ngland has not previously been estimated. In 1999, the N ational H ealth S ervice …
ngland has not previously been estimated. In 1999, the N ational H ealth S ervice …
Association Between Antiretroviral Exposure and Renal Impairment Among HIV-Positive Persons With Normal Baseline Renal Function: the D:A:D Studya
…, CA Fux, P Morlat, O Moranne, C Smith… - The Journal of …, 2013 - academic.oup.com
Background. Several antiretroviral agents (ARVs) are associated with chronic renal
impairment, but the extent of such adverse events among human immunodeficiency virus (HIV)–…
impairment, but the extent of such adverse events among human immunodeficiency virus (HIV)–…
[HTML][HTML] Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America
…, D Costagliola, A d'Arminio, M Cavassini, C Smith… - Aids, 2015 - journals.lww.com
Background: Cardiovascular disease and non-AIDS malignancies have become major
causes of death among HIV-infected individuals. The relative impact of lifestyle and HIV-related …
causes of death among HIV-infected individuals. The relative impact of lifestyle and HIV-related …
Late presenters in the era of highly active antiretroviral therapy: uptake of and responses to antiretroviral therapy
Objectives: To investigate the characteristics and clinical, immunological and virological
outcomes for individuals presenting for care with low CD4 cell counts. Methods: Individuals aged…
outcomes for individuals presenting for care with low CD4 cell counts. Methods: Individuals aged…
Systemic sclerosis associated pulmonary hypertension: improved survival in the current era
…, MR Akram, J Davar, CP Denton, CJ Smith… - Heart, 2006 - heart.bmj.com
Objectives: To measure survival, haemodynamic function and functional class in patients with
systemic sclerosis associated pulmonary arterial hypertension (SSc-PAH) in two treatment …
systemic sclerosis associated pulmonary arterial hypertension (SSc-PAH) in two treatment …